Home » PATENT IMPROVES RUBELLA TESTING ACCURACY
PATENT IMPROVES RUBELLA TESTING ACCURACY
Meridian Bioscience announced that Viral Antigens, a wholly owned life science subsidiary, received a patent entitled "Specificity in the Detection of Anti-Rubella IgM Antibodies" from the U.S. Patent and Trademark Office. This patent encompasses improved methods for detection of anti-rubella IgM antibodies in commercial diagnostic products, utilized to test blood samples for the presence of rubella antibodies.
()a href="http://menafn.com/qn_news_story.asp?StoryId=CqRJIqbKbmtCZyJC2mti" target="_blank">MENAFN
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May